2 Firms Vie To Lead Investor Suit Over Co.'s COVID Claims
By Sydney Price ( April 18, 2023, 4:57 PM EDT) -- Robbins Geller Rudman & Dowd LLP and Johnson Fistel LLP seek to jointly lead a proposed class action accusing executives of a biotech company of making empty boasts about the ability of its COVID-19 vaccine to fight the Omicron variant to inflate the stock price....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.